Jones William Benton 4
4 · Corvus Pharmaceuticals, Inc. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Jones William Benton
See Remarks
Transactions
- Exercise/Conversion
Warrant (Right to Buy)
2025-06-04−19,357→ 0 totalExercise: $3.50From: 2024-05-06Exp: 2025-06-30→ Common Stock (19,357 underlying) - Exercise/Conversion
Common Stock
2025-06-04$3.50/sh+19,357$67,750→ 173,130 total
Footnotes (1)
- [F1]Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312 per share.